|
2007 Journal Article The International Prognostic Index: the “gold-standard” in post-transplant lymphoproliferative disorders after renal transplantationHourigan, M. J., Mollee, P. N., Gill, D. S., Doecke, J., Norris, D., Johnson, D. W. and Gandhi, M. K.. (2007). The International Prognostic Index: the “gold-standard” in post-transplant lymphoproliferative disorders after renal transplantation. American Journal of Transplantation, 7, 399-399. |
|
2006 Journal Article Increased Mortality with FLA Compared with ADE Chemotherapy in High-risk AML (Letter to the Editor)Lane, Steven W., Marlton, Paula and Mollee, Peter N. (2006). Increased Mortality with FLA Compared with ADE Chemotherapy in High-risk AML (Letter to the Editor). Blood, 108 (12), 3950-3951. doi: 10.1182/blood-2006-06-032680 |
|
2006 Journal Article Characterisation and prognostic significance of WT-1 gene expression in acute myeloid leukemia (AML)Lane, Steven W., Saal, Russell, Negus, Suzanne, Mollee, Peter, Mather, M., Gill, Devinder, Mills, Anthony K., Bird, Robert J., Hourigan, Matthew J., Jones, Mark and Marlton, Paula (2006). Characterisation and prognostic significance of WT-1 gene expression in acute myeloid leukemia (AML). Blood, 108 (11). doi: 10.1182/blood.v108.11.2313.2313 |
|
2006 Journal Article The Hyper-CVAD chemotherapy regimen has an adverse long-term impact on the ability to mobilize peripheral blood stem cells, which can be readily circumvented by using the early cycles for mobilizationKeane, Colm, Gibbs, Simon, Seymour, John F., Mills, Anthony K ., Grimmett, Karen, Van Kuilenberg, Rosita, Russell, Saal, Gill, Devinder, Prince, H. Miles, Marlton, Paula and Mollee, Peter (2006). The Hyper-CVAD chemotherapy regimen has an adverse long-term impact on the ability to mobilize peripheral blood stem cells, which can be readily circumvented by using the early cycles for mobilization. Hematological Oncology, 24 (3), 159-163. doi: 10.1002/hon.784 |
|
2006 Journal Article Safety and efficacy of pegfilgrastim compared to granulocyte colony stimulating factor (G-CSF)supporting a dose-intensive, rapidly cycling anti-metabolite containing chemotherapy regimen (Hyper-CVAD) for lymphoid malignancyLane, Steven W., Crawford, Julie, Kenealy, Melita, Cull, Gavin, Seymour, John F., Prince, H. Miles, Marlton, Paula, Gill, Devinder and Mollee, Peter N. (2006). Safety and efficacy of pegfilgrastim compared to granulocyte colony stimulating factor (G-CSF)supporting a dose-intensive, rapidly cycling anti-metabolite containing chemotherapy regimen (Hyper-CVAD) for lymphoid malignancy. Leukemia and Lymphoma, 47 (9), 1813-1817. doi: 10.1080/10428190600632832 |
|
2006 Journal Article The effect of the Hyper-CVAD chemotherapy regimen on fertility and ovarian functionSeshadri, T., Hourigan, M. J., Wolf, M., Mollee, P. N. and Seymour, J. F. (2006). The effect of the Hyper-CVAD chemotherapy regimen on fertility and ovarian function. Leukemia Research, 30 (4), 483-485. doi: 10.1016/j.leukres.2005.08.014 |
|
2006 Journal Article A phase II study of thalidomide and vinblastine for palliative patients with Hodgkin's lymphomaKuruvilla, John, Song, Kevin, Mollee, Peter, Panzarella, Tony, McCrae, Jan, Nagy, Tracy, Crump, Michael and Keating, Armand (2006). A phase II study of thalidomide and vinblastine for palliative patients with Hodgkin's lymphoma. Hematology, 11 (1), 25-29. doi: 10.1080/10245330500276592 |
|
2006 Journal Article Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphomaGandhi, M. K., Lambley, E., Burrows, J., Dua, U., Elliott, S., Shaw, P. J., Prince, H. M., Wolf, M., Clarke, K., Underhill, C., Mills, T., Mollee, P., Gill, D., Marlton, P., Seymour, J. F. and Khanna, R. (2006). Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma. Clinical Cancer Research, 12 (2), 460-464. doi: 10.1158/1078-0432.CCR-05-2008 |
|
2006 Journal Article Hereditary fibrinogen A alpha-chain amyloidosisLane, S. W., Goodman, H. J., Francis, L., Bofinger, A. M. and Mollee, P. N. (2006). Hereditary fibrinogen A alpha-chain amyloidosis. Pathology, 38 (4), 380-382. doi: 10.1080/00313020600820823 |
|
2006 Journal Article Effects of hyperlipidemia on plasma sodium, potassium, and chloride measurements by an indirect ion-selective electrode measuring systemDimeski, Goce, Mollee, Peter and Carter, Andrew (2006). Effects of hyperlipidemia on plasma sodium, potassium, and chloride measurements by an indirect ion-selective electrode measuring system. Clinical Chemistry, 52 (1), 155-156. doi: 10.1373/clinchem.2005.054981 |
|
2005 Journal Article Increased Lipid Concentration Is Associated with Increased HemolysisDimeski, Goce, Mollee, Peter and Carter, Andrew (2005). Increased Lipid Concentration Is Associated with Increased Hemolysis. Clinical Chemistry, 51 (12), 2425-2425. doi: 10.1373/clinchem.2005.058644 |
|
2005 Journal Article Role of VAD in the initial treatment of multiple myelomaLane, Steven W., Gill, Devinder, Mollee, Peter N. and Rajkumar, S. Vincent (2005). Role of VAD in the initial treatment of multiple myeloma. Blood, 106 (10), 3674-3675. doi: 10.1182/blood-2005-07-2610 |
|
2005 Journal Article The reporting of serum protein electrophoresis to cliniciansTate, Jillian R., Mollee, Peter and Gill, Devinder (2005). The reporting of serum protein electrophoresis to clinicians. Clinica Chimica Acta, 358 (1-2), 204-205. doi: 10.1016/j.cccn.2005.04.010 |
|
2005 Journal Article Predictive value of karyotype on outcome of autotransplants for acute myeloid leukemia in second remissionSong, Kevin W., Mollee, Peter N., Hogge, Donna E., Gupta, Vikas, Bernett, Michael J., Forrest, Donna L., Lavoie, Julye C., Nevill, Thmas J., Nantel, Stephen H., Shepherd, John D., Smith, Clay A., Sutherland, Heather J., Toze, Cynthia L., Crump, Michael and Keating, Armand (2005). Predictive value of karyotype on outcome of autotransplants for acute myeloid leukemia in second remission. Leukemia and Lymphoma, 46 (4), 525-531. doi: 10.1080/10428190400025112 |
|
2005 Journal Article Allogeneic stem cell transplantation for mantle cell lymphoma--does it deserve a better look?Rifkind, Joshua, Mollee, Peter, Messner, Hans and Lipton, Jeffrey (2005). Allogeneic stem cell transplantation for mantle cell lymphoma--does it deserve a better look?. Leukemia & Lymphoma, 46 (2), 217-223. doi: 10.1080/10428190400015022 |
|
2005 Journal Article Serum free light chains for monitoring multiple myelomaTate, J., Mollee, P. and Gill, D. (2005). Serum free light chains for monitoring multiple myeloma. British Journal of Haematology, 128 (3), 405-406. doi: 10.1111/j.1365-2141.2004.05338.x |
|
2005 Journal Article Stem cell transplantation for mantle cell lymphoma: if, when and how?Kiss, T. L., Mollee, P., Lazarus, H. M. and Lipton, J. H. (2005). Stem cell transplantation for mantle cell lymphoma: if, when and how?. Bone Marrow Transplantation, 36 (8), 655-661. doi: 10.1038/sj.bmt.1705080 |
|
2004 Journal Article Long-term outcome after intensive therapy with etoposide, melphalan, total body irradiation and autotransplant for acute myeloid leukemiaMollee, P., Gupta, V., Song, K., Reddy, V., Califaretti, N., Tsang, R., Crump, M. and Keating, A. (2004). Long-term outcome after intensive therapy with etoposide, melphalan, total body irradiation and autotransplant for acute myeloid leukemia. Bone Marrow Transplantation, 33 (12), 1201-1208. doi: 10.1038/sj.bmt.1704506 |
|
2004 Journal Article Autologous stem cell transplantation in primary systemic amyloidosis: the impact of selection criteria on outcomeMollee, P. N., Wechalekar, A. D., Pereira, D. L., Franke, N., Reece, D., Chen, C. and Stewart, A. K. (2004). Autologous stem cell transplantation in primary systemic amyloidosis: the impact of selection criteria on outcome. Bone Marrow Transplantation, 33 (3), 271-277. doi: 10.1038/sj.bmt.1704344 |
|
2004 Journal Article Interferon-α-2b and oral cytarabine ocfosfate for newly diagnosed chronic myeloid leukaemiaMollee, P., Arthur, C., Hughes, T., Januszewicz, H., Grigg, A., Bradstock, K., Wolf, M., Gibson, J., Schwarer, A. P., Spencer, A., Browett, P., Hawkins, T., Seldon, M., Herrmann, R. and Watson, A. (2004). Interferon-α-2b and oral cytarabine ocfosfate for newly diagnosed chronic myeloid leukaemia. Annals of Oncology, 15 (12), 1810-1815. doi: 10.1093/annonc/mdh468 |
